
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Pediatr. , 06 November 2023
Sec. Pediatric Rheumatology
Volume 11 - 2023 | https://doi.org/10.3389/fped.2023.1323946
This article is part of the Research Topic Recurrent Fever in Pediatrics View all 7 articles
This article is a correction to:
Increase in pediatric recurrent fever evaluations during the first year of the COVID-19 pandemic in North America
A Corrigendum on
By Mansfield LM, Lapidus SK, Romero SN, Moorthy LN, Adler-Shohet FC, Hollander M, et al. (2023) Front. Pediatr. 11:1240242. doi: 10.3389/fped.2023.1240242
Incorrect Author Name
In the published article, an author name was incorrectly written as “Maria J. Guttierez”. The correct spelling is “Maria J. Gutierrez”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: pediatric, fevers, recurrent, COVID-19, rheumatology, CARRA
Citation: Mansfield LM, Lapidus SK, Romero SN, Moorthy LN, Adler-Shohet FC, Hollander M, Cherian J, Twilt M, Lionetti G, Mohan S, DeLaMora PA, Durrant KL, Muskardin TW, Correia Marques M, Onel KB, Dedeoglu F, Gutierrez MJ, Schulert G and the CARRA Autoinflammatory Network Consortium for the CARRA PFAPA/Autoinflammatory Working Group (2023) Corrigendum: Increase in pediatric recurrent fever evaluations during the first year of the COVID-19 pandemic in North America. Front. Pediatr. 11:1323946. doi: 10.3389/fped.2023.1323946
Received: 18 October 2023; Accepted: 19 October 2023;
Published: 6 November 2023.
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
© 2023 Mansfield, Lapidus, Romero, Moorthy, Adler-Shohet, Hollander, Cherian, Twilt, Lionetti, Mohan, DeLaMora, Durrant, Muskardin, Correia Marques, Onel, Dedeoglu, Gutierrez, Schulert and the CARRA Autoinflammatory Network Consortium for the CARRA PFAPA/Autoinflammatory Working Group. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Leanne M. Mansfield bGVhbm5lLm0uZGluZ2VzQGdtYWlsLmNvbQ==
†These authors share first authorship
‡These authors share senior authorship
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.